ICON PLC Logo

ICON PLC

Global provider of outsourced development services for pharma, biotech & medical device.

ICLR | US

Overview

Corporate Details

ISIN(s):
IE0005711209 (+1 more)
LEI:
Country:
United States of America
Address:
SOUTH COUNTY BUSINESS PARK, 0 DUBLIN 18

Description

ICON PLC is a global provider of outsourced development and commercialization services for the pharmaceutical, biotechnology, and medical device sectors. The company supports clients in accelerating the development of drugs and devices, offering a comprehensive suite of services that span the entire clinical lifecycle from "molecule to medicine." Core capabilities include consulting, early clinical and bioanalytical solutions, site and patient solutions, specialty laboratory services supporting precision medicine, and market access strategies covering pricing and reimbursement. ICON also delivers specialized biotech support, such as due diligence and asset valuation, alongside advanced cardiac safety solutions. The company integrates healthcare intelligence and technology, including artificial intelligence, to enhance clinical research processes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-14 13:59 English ZIP 12.3 KB
2025-11-12 10:33 English ZIP 11.6 KB
2025-11-12 07:50
6-K
English ZIP 50.5 KB
2025-11-03 17:23 English ZIP 7.4 KB
2025-10-23 18:35
6-K
English ZIP 1.4 MB
2025-10-22 18:28
6-K
English ZIP 71.5 KB
2025-10-02 18:03 English ZIP 7.5 KB
2025-09-24 11:06
6-K
English ZIP 50.6 KB
2025-09-04 11:38
6-K
English ZIP 49.8 KB
2025-09-04 10:05
6-K
English ZIP 52.6 KB
2025-09-02 08:21
6-K
English ZIP 50.7 KB
2025-08-26 18:18
6-K
English ZIP 5.4 MB
2025-08-12 18:17
6-K
English ZIP 50.3 KB
2025-08-12 08:03 English ZIP 189.6 KB
2025-08-08 18:33 English ZIP 6.9 KB

Automate Your Workflow. Get a real-time feed of all ICON PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ICON PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ICON PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

genOway Logo
Designs and develops genetically modified preclinical models for research.
France
ALGEN
Genprex, Inc. Logo
Clinical-stage gene therapy company developing therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
United States of America
GOVX
GH Research PLC Logo
Develops mebufotenin-based therapies for psychiatric and neurological disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Researches and develops protein-based drugs for immuno-oncology and immunology.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
Operates a horizontal platform for cell programming and synthetic biology.
United States of America
DNA
GRAIL, Inc. Logo
A healthcare company developing blood tests for multi-cancer early detection.
United States of America
GRAL
GT Biopharma, Inc. Logo
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing therapies to prevent acute kidney injury.
Sweden
GUARD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.